Report outlines measures to combat antibiotic resistance
A plan to fight back against antibiotic resistance, developed by an international consortium managed by Swiss researchers, calls for marketing incentives for research and development investments into crucial new drugs.
This content was published on
2 minutes
SDA-ATS/ln
Researchers and public health organisations have long been raising awareness about the problem of antibiotic-resistant bacteria, and the lack of new treatments being developed to combat these strains.
Now, DRIVE-ABExternal link, an international consortium of public health organisations, researchers and pharmaceutical companies piloted by the University of Geneva (UNIGE) and England-based AstraZenecaExternal link, has published a report that proposes concrete economic solutions to combat this global problem.
In particular, the writers of the report, published WednesdayExternal link, recommend a market entry reward for antibiotics fulfilling certain conditions to meet the health needs of the public, in order to create more attractive conditions for research and development investments.
They argue that such a reward – involving a series of payments to a pharmaceutical developer for getting regulatory approval for a certain antibiotic – of $1 billion (CHF940 million) per product could significantly increase the number of new drugs entering the market in the next 30 years. Such a financial incentive would be accompanied by requirements for responsible use of and equitable access to these medicines, they write.
Stephan Harbarth, a professor at the University of Geneva Faculty of Medicine and the coordinator of the DRIVE-AB project, said in a statement that implementing such incentives would take time. He emphasised that it is therefore imperative to act quickly, so that “these new antibiotics will be at our disposal in the next ten to 20 years”.
Other models analysed in the report include non-refundable research grants, the creation of government organisations to identify and fill holes in the global antibiotic pipeline, and long-term financing to guarantee a stable supply of generic antibiotics.
The consequences of antibiotic resistance are severe and on the rise. For the first time last year, Switzerland launched its own campaign in parallel to the World Health Organization’s annual Antibiotic Awareness Week, to educate the public as well as experts on issue.
Swiss electricity supply outlook positive despite uncertainties
This content was published on
Thanks to well-filled gas stores in Europe and increased availability of French nuclear power, the Swiss Federal Electricity Commission is optimistic.
Finance minister wants Swiss banks to hold more equity
This content was published on
Finance Minister Karin Keller-Sutter has repeated calls for banks and their holdings in subsidiaries abroad to hold more equity.
Telecoms sector kept Swiss competitions regulator busy in 2023
This content was published on
Last year, the Swiss Competition Commission (COMCO) conducted 27 investigations and initiated 17 preliminary investigations.
This content was published on
Although Swiss International Air Lines (SWISS) achieved higher revenue at the start of the year, it suffered a dip in profits.
40,000 signatures against animal testing in Switzerland
This content was published on
Switzerland should do away with “restrictive” animal testing and should become a model for innovative, effective, and pain-free scientific research.
More than 45,000 signatures in favour of federal funding for UNRWA
This content was published on
The Foreign Affairs Committee of the House of Representatives (FAC) is expected to decide on the funding of the UNRWA at the beginning of the week.
This content was published on
At the end of January 2024, 6,881 men and women were behind bars in Switzerland. Almost 95% of all places were occupied, the highest number since 2014.
Cases of psychological abuse of children increase in Switzerland
This content was published on
The number of cases of child abuse recorded in Swiss paediatric clinics rose to 2,097 in 2023, an all-time high, which is mainly due to improved recording.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Lucerne research finds how to cut antibiotic overuse in babies
This content was published on
Researchers has successfully tested a way of targeting antibiotic therapy in new-born babies, thereby avoiding unnecessary treatment and side effects.
This content was published on
Nina Kathe has just started classes at the University of Zurich, but she’s already the author of award-winning research into a global health concern.
Anti-pesticide farm initiative passes the signature stage
This content was published on
Campaigners have handed in signatures backing an initiative which would cut direct subsidies to farmers who use pesticides or antibiotics.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.